Aldeyra Therapeutics, Inc. ALDX
Set alert
0.60 USD +0.02 +3.00%
As of Nov 3, 1:13 PM ET
0.5526 Day range 0.6127
0.527 52-week range 5.93
- YTD
- -88.40%
- 1 year
- -88.51%
- Open
- 0.5832
- Prev close
- 0.5832
- Mkt cap
- 36.09M
- Vol
- 373.36K
- Avg vol
- 1.16M
- EPS
- -0.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5526
- High
- 0.6127
- Forward P/E
- -7.80
- Beta
- 1.43
- Short ratio
- 6.19
- Inst. own
- 62.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 3, 2024
- 50-d avg
- 5.12
- 200-d avg
- 4.48
- 1y target
- 10.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.00 +1564.7% upside
Now 0.6007
- Target (low)
- 8.00
- Target (mean)
- 10.00
- Target (high)
- 12.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.21731 | -0.28 – -0.1512 | -0.08 | -171.6% | 0 | 0.0% | 7 |
| Next quarter | -0.22 | -0.22 – -0.22 | -0.14 | -57.1% | 0 | 0.0% | 1 |
| Current year | -0.91282 | -0.99974 – -0.85 | -0.64 | -42.6% | 0 | 0.0% | 7 |
| Next year | -0.42955 | -1.00 – 1.79 | -0.91282 | +52.9% | 65.24M | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 6, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 3, 2024 | Oppenheimer | Upgrade | Perform | Outperform |
| Oct 17, 2023 | Citigroup | Maintained | Buy | Buy |
| Oct 17, 2023 | Oppenheimer | Downgrade | Outperform | Perform |
| Aug 9, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 22, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 1, 2023 | Citigroup | Maintained | Buy | Buy |
| May 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 10, 2023 | Citigroup | Maintained | Buy | Buy |
| Mar 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 21, 2022 | Citigroup | Maintained | Buy | Buy |
| Jun 9, 2022 | Citigroup | Maintained | — | Buy |
| Dec 21, 2021 | Citigroup | Maintained | — | Buy |
| Dec 21, 2021 | SVB Leerink | Maintained | — | Outperform |
| Apr 28, 2021 | Citigroup | Maintained | Buy | Buy |
| Mar 12, 2021 | Citigroup | Maintained | Buy | Buy |
| Mar 12, 2021 | SVB Leerink | Initiated | — | Outperform |
| Feb 8, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 16, 2020 | Berenberg | Initiated | — | Buy |
| Oct 30, 2020 | Jefferies | Initiated | — | Buy |
| Oct 16, 2020 | BTIG | Initiated | — | Buy |
| Aug 11, 2020 | Citigroup | Maintained | — | Buy |
| May 12, 2020 | Oppenheimer | Initiated | — | Outperform |
| Dec 4, 2018 | Citigroup | Initiated | — | Buy |